Assessing Need for Medication-Assisted Treatment for Opiate-Dependent Prison Inmates
Assessing Need for Medication-Assisted Treatment for Opiate-Dependent Prison Inmates
复制标题
DOI：
10.1080/08897077.2011.620462
复制
发表时间：
2012-01-01
期刊：
影响因子：
3.5
通讯作者：
Roman-Badenas, Luis
中科院分区：
文献类型：
--
作者：
Albizu-Garcia, Carmen E.;Caraballo, Jose Noel;Roman-Badenas, Luis
有海洛因依赖史的人在美国惩教机构中的比例过高，75%的药物使用障碍囚犯在监禁期间或释放后没有接受治疗。使用美沙酮或丁丙诺啡等阿片类激动剂的药物辅助治疗构成标准治疗;为指导规划在惩教设施中扩大戒毒治疗服务，波多黎各惩教和康复部进行了需求评估。作者报告了研究过程，研究结果为他们的建议提供了信息，以便DCR为符合条件的囚犯扩大MAT，以及吸取的教训。
Individuals with a history of heroin dependence are overrepresented in American correctional facilities and 75% of inmates with a drug use disorder do not receive treatment during incarceration or after release. Medication-assisted treatment (MAT) with opiate agonists, such as methadone or buprenorphine, constitutes standard of care; to guide planning for an expansion of drug treatment services in correctional facilities, a needs assessment was conducted at the Department of Correction and Rehabilitation (DCR) of Puerto Rico (PR). The authors report on the research process, the findings that informed their recommendations for the DCR to expand MAT for eligible inmates, and lessons learned.